Filing Details
CervoMed Inc. (NASDAQ:CRVO) filed a Form 8-K with the Securities and Exchange Commission on August 04, 2026, disclosing a material event.
8k filedNASDAQ:CRVO
CervoMed Inc. (CRVO) Reports Material Event to SEC
Filing Details CervoMed Inc. (NASDAQ:CRVO) filed a Form 8-K with the Securities and Exchange Commission on August 04, 2026, disclosing a material event. Market Context CervoMed…
Market Context
CervoMed Inc.'s stock currently trades at $2.80 with a market capitalization of $76.6M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for CervoMed Inc.'s stock.
All SEC filings for CervoMed Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CRVO Stock Page
Frequently Asked Questions
Where can I read CRVO's SEC filings?
Browse all filings on our CRVO SEC filings page.
What types of SEC filings does CervoMed Inc. file?
Public companies like CervoMed Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.